HEMO — Hemogenyx Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Hemogenyx Pharmaceuticals, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	6.84	2.53	1.25	0.159	1.59
Net Total Accounts Receivable
Net Total Receivables	0.008	0.01	0.005	0.008	0.013
Prepaid Expenses
Total Current Assets	7.14	2.59	2.17	0.839	2.03
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.797	3.92	3.31	2.73	1.8
Net Intangible Assets
Other Long Term Assets
Total Assets	8.52	7.09	6.11	4.21	4.18
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	0.353	0.748	0.652	1.16	1.47
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	0.329	3.82	3.29	3.31	2.98
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	8.19	3.28	2.82	0.898	1.2
Total Liabilities & Shareholders' Equity	8.52	7.09	6.11	4.21	4.18
Total Common Shares Outstanding